This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Molecular Cancer Open Access 21 February 2023
-
Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype
Journal of Cancer Research and Clinical Oncology Open Access 28 August 2022
-
Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes
Clinical Epigenetics Open Access 21 January 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 2005; 106: 3183–3190.
Martin-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99: 1474–1477.
Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001; 98: 3413–3420.
Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T et al. Bcl11a is essential for normal lymphoid development. Nat Immunol 2003; 4: 525–532.
Luo WJ, Takakuwa T, Ham MF, Wada N, Liu A, Fujita S et al. Epstein-Barr virus is integrated between REL and BCL-11A in American Burkitt lymphoma cell line (NAB-2). Lab Invest 2004; 84: 1193–1199.
Bea S, Colomo L, Lopez-Guillermo A, Salaverria I, Puig X, Pinyol M et al. Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas. J Clin Oncol 2004; 22: 3498–3506.
Pulford K, Banham AH, Lyne L, Jones M, Ippolito GC, Liu H et al. The BCL11A(XL) transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells. Leukemia 2006 (in press).
Senawong T, Peterson VJ, Avram D, Shepherd DM, Frye RA, Minucci S et al. Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. J Biol Chem 2003; 278: 43041–43050.
Acknowledgements
We thank Iwona Nerbas, Claudia Becher and Dorit Schuster for excellent technical assistance and Reina Zühlke-Jenisch for support with FICTION analysis. Further, we thank Dr Frank Leithäuser for technical support. This work was financed by the Deutsche Krebshilfe (106367) and the Deutsche Krebshilfe Verbundprojekt für ‘Molekulare Mechanismen bei malignen Lymphomen’ (70-3173-Tr3). KP, AHB and LL are supported by the Leukaemia Research Fund. MJSD is supported by the Medical Research Council.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)
Supplementary information
Rights and permissions
About this article
Cite this article
Weniger, M., Pulford, K., Gesk, S. et al. Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11AXL protein are frequent in primary mediastinal B-cell lymphoma. Leukemia 20, 1880–1882 (2006). https://doi.org/10.1038/sj.leu.2404324
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404324
This article is cited by
-
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Molecular Cancer (2023)
-
Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype
Journal of Cancer Research and Clinical Oncology (2023)
-
RNA-seq analysis reveals candidate genes associated with proliferation, invasion, and migration in BCL11A knockdown B-NHL cell lines
Annals of Hematology (2023)
-
Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes
Clinical Epigenetics (2022)
-
Gene expression analysis in EBV-infected ataxia-telangiectasia cell lines by RNA-sequencing reveals protein synthesis defect and immune abnormalities
Orphanet Journal of Rare Diseases (2021)